基层医疗中原发性醛固酮增多症的患病率:横断面研究
该研究在基层医疗环境中对3748例新诊断且未治疗的高血压患者进行筛查,其中343例接受醛固酮和肾素检测,74例醛固酮肾素比值升高且血浆醛固酮浓度增高者经盐水输注试验确认,9例确诊原发性醛固酮增多症,患病率为2.6%(95%CI=1.4-4.9)。所有患者血钾正常,8/9患者血压持续>150/100 mmHg。研究支持内分泌学会指南推荐的筛查策略,但筛查比例仅9.2%反映在基层开展患病率研究的困难。
要点
- 新诊断未治疗高血压患者中原发性醛固酮增多症患病率为2.6%(95%CI=1.4-4.9)。
- 确诊患者均血钾正常,8/9血压持续>150/100 mmHg。
- 研究支持内分泌学会指南的筛查策略,但实际筛查比例仅9.2%。
核心结论
- 在基层医疗新诊断未治疗高血压患者中,原发性醛固酮增多症患病率为2.6%(95%CI=1.4-4.9),低于既往其他基层研究估计。
- 研究支持内分泌学会临床实践指南推荐的筛查策略。
研究设计与样本
- 横断面研究,在基层医疗环境中由全科医生对成年新诊断且未治疗的高血压患者检测醛固酮和肾素。
- 醛固酮肾素比值升高且血浆醛固酮浓度增高者接受盐水输注试验以确认或排除原发性醛固酮增多症。
- 源人群为3748例新诊断高血压患者,其中343例接受筛查。
主要发现
- 74例醛固酮肾素比值升高且血浆醛固酮浓度增高的患者中,9例经盐水输注试验确诊原发性醛固酮增多症。
- 患病率为2.6%(95%CI=1.4-4.9)。
- 所有确诊患者血钾正常,8/9患者血压持续>150/100 mmHg。
- 接受筛查的患者较未筛查者更年轻(P<0.001)或血压更高(P<0.001)。
- 符合条件的大队列中仅9.2%接受了筛查。
关键数值与推荐
- 筛查方法:检测醛固酮和肾素,计算醛固酮肾素比值。
- 确诊方法:醛固酮肾素比值升高且血浆醛固酮浓度增高者行盐水输注试验。
- 患病率:2.6%(95%CI=1.4-4.9)。
- 筛查比例:9.2%。
临床怎么用
- 对基层新诊断未治疗高血压患者,可考虑按内分泌学会指南筛查原发性醛固酮增多症。
- 即使患者血钾正常,也需警惕原发性醛固酮增多症,尤其血压持续>150/100 mmHg者。
- 实际筛查比例低,提示需关注基层筛查的实施障碍。
局限性
- 筛查比例仅9.2%,可能存在选择偏倚。
- 接受筛查的患者更年轻或血压更高,可能影响患病率估计的外推。
- 研究为横断面设计,无法推断因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary aldosteronism (PA) is the most frequent cause of secondary hypertension. Reported prevalences of PA vary considerably because of a large heterogeneity in study methodology. AIM: To examine the proportion of patients with PA among patients with newly diagnosed, never treated hypertension. DESIGN AND SETTING: A cross-sectional study set in primary care. METHOD: GPs measured aldosterone and renin in adult patients with newly diagnosed, never treated hypertension. Patients with elevated aldosterone-to-renin ratio and increased plasma aldosterone concentration underwent a saline infusion test to confirm or exclude PA. The source population was meticulously assessed to detect possible selection bias. RESULTS: Of 3748 patients with newly diagnosed hypertension, 343 patients were screened for PA. In nine out of 74 patients with an elevated aldosterone-to-renin ratio and increased plasma aldosterone concentration the diagnosis of PA was confirmed by a saline infusion test, resulting in a prevalence of 2.6% (95% confidence interval = 1.4 to 4.9). All patients with PA were normokalaemic and 8 out of 9 patients had sustained blood pressure >150/100 mmHg. Screened patients were younger (P<0.001) or showed higher blood pressure (P<0.001) than non-screened patients. CONCLUSION: In this study a prevalence of PA of 2.6% in a primary care setting was established, which is lower than estimates reported from other primary care studies so far. This study supports the screening strategy as recommended by the Endocrine Society Clinical Practice Guideline. The low proportion of screened patients (9.2%), of the large cohort of eligible patients, reflects the difficulty of conducting prevalence studies in primary care clinical practice.
引用
- Käyser SC, Deinum J, de Grauw WJ, et al. Prevalence of primary aldosteronism in primary care: a cross-sectional study. Br J Gen Pract. 2018. PMID: 29335324. doi:10.3399/bjgp18X694589
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。